Last reviewed · How we verify
Liposarcoma
Approved treatments
- Yondelis · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Yondelis · Janssen Prods
Yondelis works by binding to DNA and causing interstrand crosslinks, thereby inhibiting cancer cell growth. - Halaven · Eisai
Halaven works by binding to tubulin beta, disrupting microtubule dynamics and leading to cell death.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Liposarcoma patent landscape — cliff calendar, originator estates, attackable patents
- Liposarcoma treatment landscape brief
- Liposarcoma treatment updates RSS
Frequently asked questions about Liposarcoma
What drugs treat Liposarcoma?
Tracked treatments include Yondelis, Halaven.
What is the treatment for Liposarcoma?
Standard treatment for Liposarcoma includes Yondelis, Halaven. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Liposarcoma patent cliff · Liposarcoma CI report
- Treatment: Yondelis · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Treatment: Yondelis · Janssen Prods
- Treatment: Halaven · Eisai
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing